1391 Results

People

  1. Vickers
    Vickers
  2. Adusumilli
    Adusumilli
  3. Marghoob
    Marghoob
  4. Scordo
    Scordo
  5. Levine
    Levine
  6. Saltz
    Saltz
  7. Cheung
    Cheung
  8. Ladanyi
    Ladanyi
  9. Lee
    Lee
  10. Abramson
    Abramson

Groups

  1. Department of Medicine (456)
  2. Surgery (266)
  3. Survivorship Research (205)
  4. Population Sciences Research Program (201)
  5. Solid Tumor Oncology Division (179)
  6. Center for Hematologic Malignancies (171)
  7. Epidemiology and Biostatistics (171)
  8. Hematologic Malignancies, Division of (170)
  9. GSK Faculty (152)
  10. Division of Subspecialty Medicine (146)
  1. "letter"
Formats
  1. Journal Article (990)
  2. Correspondence (221)
  3. Research Letter (168)
  4. Editorial (10)
  5. Miscellaneous (1)
  6. Review (1)
Groups
  1. Department of Medicine (456)
  2. Surgery (266)
  3. Survivorship Research (205)
  4. Population Sciences Research Program (201)
  5. Solid Tumor Oncology Division (179)
  6. Center for Hematologic Malignancies (171)

More Groups

People
  1. Andrew Vickers (46)
  2. Ashfaq Marghoob (18)
  3. Michael Scordo (18)
  4. Peter Bach (18)
  5. Prasad Adusumilli (18)
  6. Leonard Saltz (17)

More People

Years
  1. 2025 (45)
  2. 2024 (105)
  3. 2023 (67)
  4. 2022 (63)
  5. 2021 (32)
  6. 2020 (69)

More Years

Publications
  1. Journal of Clinical Oncology (118)
  2. New England Journal of Medicine (92)
  3. International Journal of Radiation Oncology, Biology, Physics (50)
  4. European Urology (33)
  5. JNCI: Journal of the National Cancer Institute (32)
  6. Leukemia and Lymphoma (32)

More Publications

Publishers
  1. Elsevier Inc. (154)
  2. Elsevier Science, Inc. (130)
  3. American Society of Clinical Oncology (120)
  4. Nature Publishing Group (98)
  5. Lippincott Williams & Wilkins (95)
  6. Massachusetts Medical Society (92)

More Publishers

Results (1391)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reply to: “STRIDE's efficacy and safety in Asian hepatocellular carcinoma”
    Correspondence

    Lau, G.; Abou-Alfa, G. K.; Chan, S. L.
    Journal of Hepatology (2025)

    Fulltext@MSK | Save
  • Organ preservation in rectal cancer: Fear of risks versus the risks of fear
    Correspondence

    Garcia-Aguilar, J.; Williams, H.; Weiser, M. R.; Smith, J. J.; Romesser, P. B.; Crane, C.; Qin, L. X.; Gonen, M.; Cercek, A.; Saltz, L. B.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Multicenter retrospective evaluation of treatment for high-risk acute promyelocytic leukemia: Real-world outcomes from the HERO consortium
    Research Letter

    Benitez, L. L.; Marx, K. R.; Rausch, C. R.; Buhlinger, K. M.; Clark, S. M.; Reid, J. H.; Lo, M.; Gatwood, K. S.; Profitt, S.; Shah, R.; more...
    American Journal of Hematology (2025)

    Fulltext@MSK | Save
  • In reply to Daungsupawong and Wiwanitkit
    Correspondence

    Mechalakos, J. G.; Hu, Y. C.; Kuo, L.; Zhang, L.; Shah, N.; Ballangrud, A.; Cervino, L.; Yorke, E.; Liu, Y.; Zhang, P.
    Practical Radiation Oncology (2025)

    Fulltext@MSK | Save
  • Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - A US multisite study
    Correspondence

    Epperla, N.; Shouse, G.; Grover, N. S.; Torka, P.; Annunzio, K.; Watkins, M.; Anampa-Guzmán, A.; Christian, B.; Thomas, C.; Barta, S. K.; more...
    Experimental Hematology and Oncology (2025)

    Fulltext@MSK | Save
  • Assessing AML-based risk criteria in patients with accelerated/blastphase MPN treated with less-intensive therapy
    Research Letter

    Shaw, R.; Yoon, J. J.; Johnston, H.; Davidson, M. B.; Siddon, A. J.; Shallis, R. M.; Chen, E. C.; Burkart, M.; Oh, T. S.; Iyer, S. G.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemia
    Research Letter

    Akiyama, H.; Nishida, Y.; Chang, K. H.; Bedoy, A. D.; Muftuoglu, M.; Ma, W.; Basyal, M.; Hirschi, Z.; Honma, D.; Tsutsumi, S.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: A prospective pilot study
    Research Letter

    Pegoraro, F.; Catamerò, F.; Allegretta, F.; Palazzini, G.; Peyronel, F.; Diamond, E. L.; Vaglio, A.
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Supernumerary ring chromosome 1 syndrome leads to fusion-driven B-cell acute lymphoblastic leukemia in monozygotic twins
    Research Letter

    Gutiérrez-Abril, J.; Gundem, G.; Fiala, E.; Liosis, K.; Farnoud, N.; Leongamornlert, D.; Amallraja, A.; Arango-Ossa, J. E.; Domenico, D.; Levine, M.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Reply to the letter to the editor by Perez et al. regarding “survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: A pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials”
    Correspondence

    Garcia-Aguilar, J.; Williams, H.; Fokas, E.; Rodel, C.
    Annals of Oncology (2025)

    Fulltext@MSK | Save